• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editor's presentation: 'Les liaisones dangerouses. The heart in the time of COVID-19'.编辑介绍：《危险关系。新冠疫情下的心脏》
Eur J Prev Cardiol. 2020 Jul;27(10):1011-1013. doi: 10.1177/2047487320936413.
2
[ANMCO Position paper: Cardiological outpatient activities in the transition phase of the COVID-19 pandemic].[意大利心脏病学会立场文件：新冠疫情过渡阶段的心脏病门诊活动]
G Ital Cardiol (Rome). 2020 Aug;21(8):584-588. doi: 10.1714/3405.33889.
3
Cardiovascular disease and COVID-19: les liaisons dangereuses.心血管疾病与 COVID-19：危险的关联。
Eur J Prev Cardiol. 2020 Jul;27(10):1017-1025. doi: 10.1177/2047487320924501. Epub 2020 May 11.
4
[ANMCO Position paper: Role of cardiology in the management of health needs in the post-COVID-19 era].[意大利心脏病学与心血管外科学会立场文件：心脏病学在新冠疫情后时代健康需求管理中的作用]
G Ital Cardiol (Rome). 2020 Jul;21(7):509-513. doi: 10.1714/3386.33636.
5
May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?他汀类药物和前蛋白转化酶枯草溶菌素9（PCSK9）抑制剂对家族性高胆固醇血症患者是否具有预防新型冠状病毒肺炎（COVID-19）的作用？
Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1068-1069. doi: 10.1016/j.numecd.2020.05.003. Epub 2020 May 13.
6
Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective.《COVID-19 大流行对心血管的影响：全球视角》
Can J Cardiol. 2020 Jul;36(7):1068-1080. doi: 10.1016/j.cjca.2020.05.018. Epub 2020 May 16.
7
COVID-19 pandemic and medical publication.2019冠状病毒病大流行与医学出版物
Eur J Clin Invest. 2020 Nov;50(11):e13394. doi: 10.1111/eci.13394. Epub 2020 Sep 21.
8
Cardiovascular Implications of COVID-19 Infections.新型冠状病毒肺炎感染的心血管影响
Methodist Debakey Cardiovasc J. 2020 Apr-Jun;16(2):146-154. doi: 10.14797/mdcj-16-2-146.
9
A close-up on COVID-19 and cardiovascular diseases.聚焦 COVID-19 与心血管疾病。
Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1057-1060. doi: 10.1016/j.numecd.2020.04.001. Epub 2020 Apr 8.
10
Outpatient Teledermatology Implementation During the COVID-19 Pandemic: Challenges and Lessons Learned.COVID-19大流行期间门诊远程皮肤病学的实施：挑战与经验教训
J Drugs Dermatol. 2020 Jun 1;19(6):683.

本文引用的文献

1
Accreditation of clinical centres providing primary prevention, secondary prevention and rehabilitation, and sports cardiology: A step towards optimizing quality.
Eur J Prev Cardiol. 2019 Nov;26(16):1775-1777. doi: 10.1177/2047487319867503. Epub 2019 Jul 30.
2
The association of resistance training with mortality: A systematic review and meta-analysis.抗阻训练与死亡率的关系：系统评价和荟萃分析。
Eur J Prev Cardiol. 2019 Oct;26(15):1647-1665. doi: 10.1177/2047487319850718. Epub 2019 May 19.
3
Dietary components and risk of cardiovascular disease and all-cause mortality: a review of evidence from meta-analyses.饮食成分与心血管疾病和全因死亡率的风险：荟萃分析证据综述。
Eur J Prev Cardiol. 2019 Sep;26(13):1415-1429. doi: 10.1177/2047487319843667. Epub 2019 Apr 11.
4
ESC e-Cardiology Working Group Position Paper: Overcoming challenges in digital health implementation in cardiovascular medicine.ESC 电子心脏病学工作组立场文件：克服心血管医学中数字健康实施的挑战。
Eur J Prev Cardiol. 2019 Jul;26(11):1166-1177. doi: 10.1177/2047487319832394. Epub 2019 Mar 27.
5
Mobile health and implantable cardiac devices: Patients' expectations.移动医疗和植入式心脏设备：患者的期望。
Eur J Prev Cardiol. 2019 Jun;26(9):920-927. doi: 10.1177/2047487319830531. Epub 2019 Mar 1.
6
Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels - experimental and clinical approaches with lipid-lowering agents.循环前蛋白转化酶枯草溶菌素 9 水平的变化 - 降脂药物的实验和临床方法。
Eur J Prev Cardiol. 2019 Jun;26(9):930-949. doi: 10.1177/2047487319831500. Epub 2019 Feb 18.
7
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.27 个国家的冠心病患者生活方式及对心血管危险因素控制的影响：欧洲心脏病学会 ESC-EORP EUROASPIRE V 注册研究结果。
Eur J Prev Cardiol. 2019 May;26(8):824-835. doi: 10.1177/2047487318825350. Epub 2019 Feb 10.
8
The educational gradient in premature cardiovascular mortality: Examining mediation by risk factors in cohorts born in the 1930s, 1940s and 1950s.教育程度与早发性心血管死亡率的关系：对 20 世纪 30 年代、40 年代和 50 年代出生队列中风险因素的中介作用进行研究。
Eur J Prev Cardiol. 2019 Jul;26(10):1096-1103. doi: 10.1177/2047487319826274. Epub 2019 Jan 28.
9
Safety and efficacy of aerobic exercise commenced early after cardiac surgery: A systematic review and meta-analysis.心脏手术后早期开始有氧运动的安全性和有效性：系统评价和荟萃分析。
Eur J Prev Cardiol. 2019 Jan;26(1):36-45. doi: 10.1177/2047487318798924. Epub 2018 Sep 6.
10
Effects of an intensive long-term prevention programme after myocardial infarction - a randomized trial.心肌梗死后强化长期预防方案的效果 - 一项随机试验。
Eur J Prev Cardiol. 2019 Mar;26(5):522-530. doi: 10.1177/2047487318781109. Epub 2018 Jun 18.

Editor's presentation: 'Les liaisones dangerouses. The heart in the time of COVID-19'.

作者信息

Piepoli Massimo F

机构信息

Heart Failure Unit, G da Saliceto Hospital, Italy.

Institute of Life Sciences, Sant'Anna School of Advanced Studies, Italy.

出版信息

Eur J Prev Cardiol. 2020 Jul;27(10):1011-1013. doi: 10.1177/2047487320936413.

DOI:10.1177/2047487320936413
PMID:32583735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7717246/
Abstract
摘要